Literature DB >> 22592590

Sexual frequency and planning among at-risk men who have sex with men in the United States: implications for event-based intermittent pre-exposure prophylaxis.

Jonathan E Volk1, Albert Liu, Eric Vittinghoff, Risha Irvin, Elizabeth Kroboth, Douglas Krakower, Matthew J Mimiaga, Kenneth H Mayer, Patrick S Sullivan, Susan P Buchbinder.   

Abstract

Intermittent dosing of pre-exposure prophylaxis (iPrEP) has potential to decrease costs, improve adherence, and minimize toxicity. Practical event-based dosing of iPrEP requires men who have sex with men (MSM) to be sexually active on fewer than 3 days each week and plan for sexual activity. MSM who may be most suitable for event-based dosing were older, more educated, more frequently used sexual networking websites, and more often reported that their last sexual encounter was not with a committed partner. A substantial proportion of these MSM endorse high-risk sexual activity, and event-based iPrEP may best target this population.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22592590      PMCID: PMC3427423          DOI: 10.1097/QAI.0b013e31825bd87d

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  8 in total

Review 1.  Condom use measurement in 56 studies of sexual risk behavior: review and recommendations.

Authors:  Seth M Noar; Christi Cole; Kellie Carlyle
Journal:  Arch Sex Behav       Date:  2006-06-24

2.  A comparison of on-line and off-line sexual risk in men who have sex with men: an event-based on-line survey.

Authors:  Mary Ann Chiasson; Sabina Hirshfield; Robert H Remien; Mike Humberstone; Tom Wong; Richard J Wolitski
Journal:  J Acquir Immune Defic Syndr       Date:  2007-02-01       Impact factor: 3.731

3.  Antiretroviral drug exposure in the female genital tract: implications for oral pre- and post-exposure prophylaxis.

Authors:  Julie B Dumond; Rosa F Yeh; Kristine B Patterson; Amanda H Corbett; Byung Hwa Jung; Naser L Rezk; Arlene S Bridges; Paul W Stewart; Myron S Cohen; Angela D M Kashuba
Journal:  AIDS       Date:  2007-09-12       Impact factor: 4.177

4.  Intermittent prophylaxis with oral truvada protects macaques from rectal SHIV infection.

Authors:  J Gerardo García-Lerma; Mian-er Cong; James Mitchell; Ae S Youngpairoj; Qi Zheng; Silvina Masciotra; Amy Martin; Zsuzsanna Kuklenyik; Angela Holder; Jonathan Lipscomb; Chou-Pong Pau; John R Barr; Debra L Hanson; Ron Otten; Lynn Paxton; Thomas M Folks; Walid Heneine
Journal:  Sci Transl Med       Date:  2010-01-13       Impact factor: 17.956

Review 5.  Pharmacological considerations for tenofovir and emtricitabine to prevent HIV infection.

Authors:  Peter L Anderson; Jennifer J Kiser; Edward M Gardner; Joseph E Rower; Amie Meditz; Robert M Grant
Journal:  J Antimicrob Chemother       Date:  2010-11-30       Impact factor: 5.790

6.  Sex frequency and sex planning among men who have sex with men in Bangkok, Thailand: implications for pre- and post-exposure prophylaxis against HIV infection.

Authors:  Frits van Griensven; Warunee Thienkrua; Wichuda Sukwicha; Wipas Wimonsate; Supaporn Chaikummao; Anchalee Varangrat; Philip A Mock
Journal:  J Int AIDS Soc       Date:  2010-04-14       Impact factor: 5.396

7.  Risk factors for HIV infection among men who have sex with men.

Authors:  Beryl A Koblin; Marla J Husnik; Grant Colfax; Yijian Huang; Maria Madison; Kenneth Mayer; Patrick J Barresi; Thomas J Coates; Margaret A Chesney; Susan Buchbinder
Journal:  AIDS       Date:  2006-03-21       Impact factor: 4.177

8.  Prevention of rectal SHIV transmission in macaques by daily or intermittent prophylaxis with emtricitabine and tenofovir.

Authors:  J Gerardo García-Lerma; Ron A Otten; Shoukat H Qari; Eddie Jackson; Mian-Er Cong; Silvina Masciotra; Wei Luo; Caryn Kim; Debra R Adams; Michael Monsour; Jonathan Lipscomb; Jeffrey A Johnson; David Delinsky; Raymond F Schinazi; Robert Janssen; Thomas M Folks; Walid Heneine
Journal:  PLoS Med       Date:  2008-02       Impact factor: 11.069

  8 in total
  17 in total

1.  Medication adherence among men who have sex with men at risk for HIV infection in the United States: implications for pre-exposure prophylaxis implementation.

Authors:  Albert Y Liu; Nancy A Hessol; Eric Vittinghoff; K Rivet Amico; Elizabeth Kroboth; Jonathan Fuchs; Risha Irvin; R Craig Sineath; Travis Sanchez; Patrick S Sullivan; Susan P Buchbinder
Journal:  AIDS Patient Care STDS       Date:  2014-12       Impact factor: 5.078

2.  On-Demand Oral Pre-exposure Prophylaxis with Tenofovir/Emtricitabine: What Every Clinician Needs to Know.

Authors:  Parya Saberi; Hyman M Scott
Journal:  J Gen Intern Med       Date:  2020-01-21       Impact factor: 5.128

3.  Sexual Behavior Patterns and PrEP Dosing Preferences in a Large Sample of North American Men Who Have Sex With Men.

Authors:  Conor Stack; Catie Oldenburg; Matthew Mimiaga; Steven A Elsesser; Douglas Krakower; David S Novak; James E Egan; Ronald Stall; Steve Safren; Kenneth H Mayer
Journal:  J Acquir Immune Defic Syndr       Date:  2016-01-01       Impact factor: 3.731

4.  Temporal Fluctuations in Behavior, Perceived HIV Risk, and Willingness to Use Pre-Exposure Prophylaxis (PrEP).

Authors:  Kristen Underhill; Kate M Guthrie; Christopher Colleran; Sarah K Calabrese; Don Operario; Kenneth H Mayer
Journal:  Arch Sex Behav       Date:  2018-01-11

5.  Maximizing the Benefits of HIV Preexposure Prophylaxis.

Authors:  Susan P Buchbinder
Journal:  Top Antivir Med       Date:  2018-04

6.  Accuracy of highly sexually active gay and bisexual men's predictions of their daily likelihood of anal sex and its relevance for intermittent event-driven HIV pre-exposure prophylaxis.

Authors:  Jeffrey T Parsons; H Jonathon Rendina; Christian Grov; Ana Ventuneac; Brian Mustanski
Journal:  J Acquir Immune Defic Syndr       Date:  2015-04-01       Impact factor: 3.731

7.  Preferences for daily or intermittent pre-exposure prophylaxis regimens and ability to anticipate sex among HIV uninfected members of Kenyan HIV serodiscordant couples.

Authors:  Sarah T Roberts; Renee Heffron; Kenneth Ngure; Connie Celum; Ann Kurth; Kathryn Curran; Nelly Mugo; Jared M Baeten
Journal:  AIDS Behav       Date:  2014-09

Review 8.  Nondaily preexposure prophylaxis for HIV prevention.

Authors:  Peter L Anderson; J Gerardo García-Lerma; Walid Heneine
Journal:  Curr Opin HIV AIDS       Date:  2016-01       Impact factor: 4.283

9.  Are Anal Sex Roles Associated with Preferences for Pre-Exposure Prophylaxis Administration Modalities Among Men Who Have Sex with Men?

Authors:  William C Goedel; John A Schneider; H Rhodes Hambrick; Noah T Kreski; Jace G Morganstein; Su Hyun Park; Ofole Mgbako; Dustin T Duncan
Journal:  Arch Sex Behav       Date:  2017-11-30

Review 10.  Challenges and opportunities for oral pre-exposure prophylaxis in the prevention of HIV infection: where are we in Europe?

Authors:  Jean-Michel Molina; Claire Pintado; Caroline Gatey; Diane Ponscarme; Pierre Charbonneau; Benedicte Loze; Willy Rozenbaum; Constance Delaugerre
Journal:  BMC Med       Date:  2013-08-23       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.